Indivior PLC (INDV)
USD 9.11
(-2.98%)
USD 9.11
(-2.98%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 1.95 Billion USD | 9.71% |
| 2022 | 1.77 Billion USD | -2.73% |
| 2021 | 1.82 Billion USD | 19.43% |
| 2020 | 1.53 Billion USD | -7.32% |
| 2019 | 1.65 Billion USD | 6.79% |
| 2018 | 1.54 Billion USD | 7.13% |
| 2017 | 1.44 Billion USD | 19.44% |
| 2016 | 1.2 Billion USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 1.46 Billion USD | -4.64% |
| 2024 Q2 | 1.53 Billion USD | 5.74% |
| 2024 Q1 | 1.45 Billion USD | -25.59% |
| 2023 FY | 1.95 Billion USD | 9.71% |
| 2023 Q4 | 1.95 Billion USD | 5.43% |
| 2023 Q3 | 1.85 Billion USD | 7.09% |
| 2023 Q2 | 1.72 Billion USD | -1.28% |
| 2023 Q1 | 1.75 Billion USD | -1.58% |
| 2022 Q1 | 1.71 Billion USD | -5.95% |
| 2022 Q2 | 1.72 Billion USD | 0.24% |
| 2022 Q3 | 1.67 Billion USD | -3.09% |
| 2022 Q4 | 1.77 Billion USD | 6.47% |
| 2021 Q4 | 1.82 Billion USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Journey Medical Corporation | 76.84 Million USD | -2439.058% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | -115.745% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | -3298.309% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | -23.937% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -7035.129% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | -7035.129% |
| SCYNEXIS, Inc. | 128.41 Million USD | -1419.516% |
| Safety Shot Inc | 12.7 Million USD | -15253.005% |
| Alpha Teknova, Inc. | 128.58 Million USD | -1417.448% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | -70.666% |
| Bright Green Corporation | 17.4 Million USD | -11112.065% |
| Dynavax Technologies Corporation | 997.09 Million USD | -95.692% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -848.143% |
| Cosmos Health Inc. | 66.29 Million USD | -2843.245% |
| PainReform Ltd. | 9.93 Million USD | -19549.959% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | -8337.048% |
| Embecta Corp. | 1.21 Billion USD | -60.675% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | -167.919% |
| Procaps Group, S.A. | 460.18 Million USD | -324.01% |
| Theratechnologies Inc. | 77.76 Million USD | -2409.022% |
| Harrow Health, Inc. | 311.75 Million USD | -525.889% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -13001.732% |
| Biofrontera Inc. | 27.93 Million USD | -6885.683% |
| DURECT Corporation | 45.18 Million USD | -4217.956% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -38.486% |
| Cronos Group Inc. | 1.13 Billion USD | -72.029% |
| OptiNose, Inc. | 107.72 Million USD | -1711.25% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | -314.212% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -3387.535% |
| RedHill Biopharma Ltd. | 23.04 Million USD | -8366.306% |
| Organogenesis Holdings Inc. | 460.02 Million USD | -324.16% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -16271.975% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | -2286.078% |
| Radius Health, Inc. | 1.71 Billion USD | -13.712% |
| Universe Pharmaceuticals INC | 53.28 Million USD | -3561.756% |
| ProPhase Labs, Inc. | 91.92 Million USD | -2022.598% |
| Phibro Animal Health Corporation | 982.18 Million USD | -98.663% |
| Procaps Group S.A. | 460.18 Million USD | -324.01% |
| Alvotech | 950.09 Million USD | -105.374% |
| TherapeuticsMD, Inc. | 43.3 Million USD | -4405.394% |
| Viatris Inc. | 47.68 Billion USD | 95.908% |
| Rockwell Medical, Inc. | 52.17 Million USD | -3639.944% |
| Aytu BioPharma, Inc. | 118.09 Million USD | -1552.264% |
| SIGA Technologies, Inc. | 254.83 Million USD | -665.684% |
| Tilray Brands, Inc. | 4.33 Billion USD | 54.992% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | -612.907% |
| Shineco, Inc. | 84.17 Million USD | -2217.956% |
| PetIQ, Inc. | 868.22 Million USD | -124.739% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -23023.87% |
| Incannex Healthcare Limited | 17.04 Million USD | -11346.243% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 39.988% |
| Alimera Sciences, Inc. | 153.52 Million USD | -1170.968% |
| Silver Spike Investment Corp. | 88.57 Million USD | -2102.894% |
| Assertio Holdings, Inc. | 286.41 Million USD | -581.254% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -32684.401% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | -5673.621% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | -6145.37% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -14629.084% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | -647.241% |
| Hempacco Co., Inc. | 18.04 Million USD | -10714.345% |
| Talphera, Inc. | 20.39 Million USD | -9467.252% |
| Alvotech | 950.09 Million USD | -105.374% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | -380.412% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | -18.175% |
| Currenc Group, Inc. | 141.49 Million USD | -1279.062% |
| Kamada Ltd. | 351.96 Million USD | -454.377% |
| Evoke Pharma, Inc. | 7.06 Million USD | -27504.559% |
| Flora Growth Corp. | 23.62 Million USD | -8158.871% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -14629.084% |
| Evolus, Inc. | 188.99 Million USD | -932.414% |
| HUTCHMED (China) Limited | 1.27 Billion USD | -52.468% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | -28.973% |
| Akanda Corp. | 8.83 Million USD | -21972.879% |